HEPION PHARMACEUTICALS, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- HEPION PHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-06-30 was $672.82K.
- HEPION PHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-03-31 was $9.76M.
- HEPION PHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2023-03-31 was $0.00.
- HEPION PHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2022-03-31 was $0.00.
- HEPION PHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2025 was $10.43M.
- HEPION PHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $0.00.
- HEPION PHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2022 was $0.00.
- HEPION PHARMACEUTICALS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2021 was $0.00.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2025-12-31 | $10.43M 10-K · filed 2026-03-12 | |
| 2025-06-30 | $672.82K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $9.76M 10-Q · filed 2026-08-13 | |
| 2023-12-31 | $0.00 10-K · filed 2024-04-16 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-21 | |
| 2022-12-31 | $0.00 10-K · filed 2024-04-16 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-11-20 | |
| 2021-12-31 | $0.00 10-K · filed 2023-04-10 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $0.00 10-K · filed 2022-04-08 | |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 | |
| 2019-03-31 | $0.00 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |